Combined treatment of pancreatic cancer with mithramycin A and tolfenamic acid promotes Sp1 degradation and synergistic antitumor activity - Response

J. Jack Lee, Maiying Kong

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Combined treatment of pancreatic cancer with mithramycin A and tolfenamic acid promotes Sp1 degradation and synergistic antitumor activity - Response'. Together they form a unique fingerprint.